Massachusetts Financial Services’s Travere Therapeutics TVTX Stock Holding History

Massachusetts Financial Services’s Portfolio TVTX Stock Details TVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$810K	Buy	+14,253	New	+$632K	﹤0.01%	906
2022 Q1	–	Sell	-81,037	Closed	-$2.52M	–	903
2021 Q4	$2.52M	Sell	81,037 -1,642	-2%	-$46.2K	﹤0.01%	755
2021 Q3	$2M	Sell	82,679 -17,062	-17%	-$313K	﹤0.01%	783
2021 Q2	$1.46M	Buy	99,741 +856	+0.9%	+$16.9K	﹤0.01%	811
2021 Q1	$2.47M	Sell	98,885 -11,719	-11%	-$324K	﹤0.01%	743
2020 Q4	$3.02M	Sell	110,604 -1,108	-1%	-$25.9K	﹤0.01%	700
2020 Q3	$2.06M	Sell	111,712 -4,377	-4%	-$85.1K	﹤0.01%	714
2020 Q2	$2.37M	Buy	116,089 +27,664	+31%	+$440K	﹤0.01%	674
2020 Q1	$1.29M	Buy	88,425 +13,995	+19%	+$211K	﹤0.01%	716
2019 Q4	$1.06M	Buy	74,430 +17,587	+31%	+$225K	﹤0.01%	756
2019 Q3	$658K	Buy	+56,843	New	+$939K	﹤0.01%	787

Other funds holding TVTX

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services's TVTX Position: Q2 2026 in Review

Massachusetts Financial Services opened a new position in Travere Therapeutics (TVTX) in Q2 2026: 14,253 shares worth $810K. The stake represents ﹤0.01% of the portfolio and ranks #906 among its holdings. This is a return to the name: Massachusetts Financial Services previously reported a position in TVTX as recently as Q4 2021.

Massachusetts Financial Services first reported a position in TVTX in Q3 2019 and has held it in 11 quarters since. The position peaked at $3.02M in Q4 2020. 321 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.

Massachusetts Financial Services held 14,253 shares of Travere Therapeutics worth $810K as of Q2 2026.
Travere Therapeutics was a new Massachusetts Financial Services position in Q2 2026.
Travere Therapeutics made up ﹤0.01% of Massachusetts Financial Services's portfolio in Q2 2026, its #906 holding.
Massachusetts Financial Services first reported a position in Travere Therapeutics in Q3 2019 and has held it in 11 quarters since.
Massachusetts Financial Services's Travere Therapeutics position peaked at $3.02M in Q4 2020.
321 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.